Literature DB >> 24687852

Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain.

Giovanni Piccoli1, Franco Onofri2, Maria Daniela Cirnaru3, Christoph J O Kaiser4, Pravinkumar Jagtap5, Andreas Kastenmüller4, Francesca Pischedda3, Antonella Marte2, Felix von Zweydorf6, Andreas Vogt7, Florian Giesert8, Lifeng Pan9, Flavia Antonucci10, Christina Kiel11, Mingjie Zhang9, Sevil Weinkauf4, Michael Sattler5, Carlo Sala3, Michela Matteoli10, Marius Ueffing7, Christian Johannes Gloeckner12.   

Abstract

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic Parkinson's disease (PD). LRRK2 is a complex protein that consists of multiple domains, including predicted C-terminal WD40 repeats. In this study, we analyzed functional and molecular features conferred by the WD40 domain. Electron microscopic analysis of the purified LRRK2 C-terminal domain revealed doughnut-shaped particles, providing experimental evidence for its WD40 fold. We demonstrate that LRRK2 WD40 binds and sequesters synaptic vesicles via interaction with vesicle-associated proteins. In fact, a domain-based pulldown approach combined with mass spectrometric analysis identified LRRK2 as being part of a highly specific protein network involved in synaptic vesicle trafficking. In addition, we found that a C-terminal sequence variant associated with an increased risk of developing PD, G2385R, correlates with a reduced binding affinity of LRRK2 WD40 to synaptic vesicles. Our data demonstrate a critical role of the WD40 domain within LRRK2 function.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24687852      PMCID: PMC4054300          DOI: 10.1128/MCB.00914-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Structural and functional analysis of essential pre-mRNA splicing factor Prp19p.

Authors:  Melanie D Ohi; Craig W Vander Kooi; Joshua A Rosenberg; Liping Ren; Justin P Hirsch; Walter J Chazin; Thomas Walz; Kathleen L Gould
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

2.  Genetics of Parkinson's disease: LRRK2 on the rise.

Authors:  Alexis Brice
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism.

Authors:  Z Xia; H Dudek; C K Miranti; M E Greenberg
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

Review 5.  Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease.

Authors:  Eng-King Tan
Journal:  Ann Acad Med Singapore       Date:  2006-11       Impact factor: 2.473

Review 6.  Description of Parkinson's disease as a clinical syndrome.

Authors:  Stanley Fahn
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

7.  GTPase activity plays a key role in the pathobiology of LRRK2.

Authors:  Yulan Xiong; Candice E Coombes; Austin Kilaru; Xiaojie Li; Aaron D Gitler; William J Bowers; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

8.  ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2?

Authors:  Frank Gillardon; Elisabeth Kremmer; Thomas Froehlich; Marius Ueffing; Bastian Hengerer; Christian J Gloeckner
Journal:  J Neurosci Methods       Date:  2013-01-12       Impact factor: 2.390

9.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  A method for WD40 repeat detection and secondary structure prediction.

Authors:  Yang Wang; Fan Jiang; Zhu Zhuo; Xian-Hui Wu; Yun-Dong Wu
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  43 in total

1.  Upregulation of Parkin in endophilin mutant mice.

Authors:  Mian Cao; Ira Milosevic; Silvia Giovedi; Pietro De Camilli
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

Review 2.  Parkinson's disease: convergence on synaptic homeostasis.

Authors:  Sandra-Fausia Soukup; Roeland Vanhauwaert; Patrik Verstreken
Journal:  EMBO J       Date:  2018-07-31       Impact factor: 11.598

Review 3.  Proteomics; applications in familial Parkinson's disease.

Authors:  Yan Li; Mark R Cookson
Journal:  J Neurochem       Date:  2019-07-09       Impact factor: 5.372

Review 4.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 5.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

6.  Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.

Authors:  Ping-Yue Pan; Xianting Li; Jing Wang; James Powell; Qian Wang; Yuanxi Zhang; Zhaoyu Chen; Bridget Wicinski; Patrick Hof; Timothy A Ryan; Zhenyu Yue
Journal:  J Neurosci       Date:  2017-10-20       Impact factor: 6.167

Review 7.  The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Authors:  Rebekah G Langston; Iakov N Rudenko; Mark R Cookson
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

8.  Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.

Authors:  Bridget A Matikainen-Ankney; Nebojsa Kezunovic; Roxana E Mesias; Yuan Tian; Frances M Williams; George W Huntley; Deanna L Benson
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

Review 9.  Oxidative stress factors in Parkinson's disease.

Authors:  Jolanta Dorszewska; Marta Kowalska; Michał Prendecki; Thomas Piekut; Joanna Kozłowska; Wojciech Kozubski
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

10.  The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning.

Authors:  Erin N Bobeck; Ivone Gomes; Darlene Pena; Kirstie A Cummings; Roger L Clem; Mihaly Mezei; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2017-04-20       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.